Market Research Reports and Industry Reports

OPX Biotechnologies, Inc. - Clean Technology - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Summary

OPX Biotechnologies, Inc. (OPX Biotech) is a biochemistry company that develops and produces bio-based chemicals and delivers petro-based chemicals. The companys products pipeline include bioacrylic and fatty acids. Its bioacrylic is a replacement for petro-acrylic that is used in consumer and industrial applications such as paints, adhesives, diapers, and detergents. The companys fatty acids find applications in flavours and fragrances, personal care products, cleaning products, lubricants and oil field chemicals. It has collaborations with chemical companies, renewable energy laboratories, and others. OPX Biotech is headquartered in Boulder, Colorado, the US.

OPX Biotechnologies, Inc. - Clean Technology - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Clean Technology eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
OPX Biotechnologies, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 5
OPX Biotechnologies, Inc., Clean Technology Deals By Type, 2009 to YTD 2015 6
OPX Biotechnologies, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 7
OPX Biotechnologies, Inc., Clean Technology, Deals By Sector, 2009 to YTD 2015 8
OPX Biotechnologies, Inc., Clean Technology, Deals Summary, 2009 to YTD 2015 9
OPX Biotechnologies, Inc., Clean Technology, Deal Details 10
Venture Financing 10
OPX Biotechnologies To Raise US$35 Million In Series D Financing 10
OPX Biotechnologies Secures US$36.5 Million In Venture Financing Round 11
OPX Biotechnologies Secures US$17.5 Million In Financing 12
OPX Biotechnologies Secures US$12.1 Million In Series C Round Of Venture Financing 13
OPX Biotechnologies, Inc. - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Other Significant Developments 17
Oct 16, 2014: OPX Biotechnologies appoints Michael J. Rosenberg as President and Chief Executive Officer 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


OPX Biotechnologies, Inc., Clean Technology, Key Facts 1
OPX Biotechnologies, Inc., Clean Technology, Deals Summary, 2009 to YTD 2015 1
OPX Biotechnologies, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 5
OPX Biotechnologies, Inc., Clean Technology Deals By Type, 2009 to YTD 2015 6
OPX Biotechnologies, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 7
OPX Biotechnologies, Inc., Deals By Sector, 2009 to YTD 2015 8
OPX Biotechnologies, Inc., Clean Technology, Deals Summary, 2009 to YTD 2015 9
OPX Biotechnologies To Raise US$35 Million In Series D Financing 10
OPX Biotechnologies Secures US$36.5 Million In Venture Financing Round 11
OPX Biotechnologies Secures US$17.5 Million In Financing 12
OPX Biotechnologies Secures US$12.1 Million In Series C Round Of Venture Financing 13
OPX Biotechnologies, Inc., Key Competitors 14
OPX Biotechnologies, Inc., Key Employees 15

List Of Figures


OPX Biotechnologies, Inc., Clean Technology, Deals by Type, 2009 to YTD 2015 1
OPX Biotechnologies, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 1
OPX Biotechnologies, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 1
OPX Biotechnologies, Inc., Clean Technology, Deals By Sector, 2009 to YTD 2015 1
OPX Biotechnologies, Inc., Clean Technology, Deals By Year, 2009 to YTD 2015 5
OPX Biotechnologies, Inc., Clean Technology, Deals by Type, 2009 to YTD 2015 6
OPX Biotechnologies, Inc., Clean Technology, Deals By Region, 2009 to YTD 2015 7
OPX Biotechnologies, Inc., Clean Technology, Deals by Sector, 2009 to YTD 2015 8

OPX Biotechnologies, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

OPX Biotechnologies, Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Opexa Therapeutics, Inc. (OPXA) - Medical Equipment - Deals and Alliances Profile

Opexa Therapeutics, Inc. (Opexa), formerly PharmaFrontiers Corp. is a biotechnology company that develops autologous cellular therapies for the treatment of sclerosis, rheumatoid arthritis, neuromyelitis optica, diabetes and heart failure. The

USD 250View Report

Opexa Therapeutics, Inc. (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Opexa Therapeutics, Inc. (Opexa), formerly PharmaFrontiers Corp. is a biotechnology company that develops autologous cellular therapies for the treatment of sclerosis, rheumatoid arthritis, neuromyelitis optica, diabetes and heart failure. The

USD 250View Report

Stellar Biotechnologies, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Stellar Biotechnologies, Inc. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

OPX Biotechnologies, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

OPX Biotechnologies, Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Compass Biotechnologies, Inc... Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Compass Biotechnologies, Inc... Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 250
  • Site Licence    $ 500
  • Enterprisewide Licence    $ 750
$ 250

Reports Details

Published Date : Sep 2015
No. of Pages :18
Country :United States of America
Category :Clean Technology
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment